1
项与 Allogenic islet cells(The University of Chicago) 相关的临床试验 / Active, not recruiting临床1/2期IIT Allogenic Islet Cells (Human, U. of Chicago) Administered Via Intraportal Infusion; and Immunosuppressive Therapy
The purpose of this study is to determine the safety of transplanting human islet cells for controlling hyperglycemia in brittle and/or complex patients with type 1 diabetes. In addition, initial observations will be made with regards to the effectiveness of reversing hypoglycemia with this treatment. The "Edmonton Protocol" of using specific anti-rejection drugs without steroids is also being evaluated.
100 项与 Allogenic islet cells(The University of Chicago) 相关的临床结果
100 项与 Allogenic islet cells(The University of Chicago) 相关的转化医学
100 项与 Allogenic islet cells(The University of Chicago) 相关的专利(医药)
100 项与 Allogenic islet cells(The University of Chicago) 相关的药物交易